ConductScience.org, home

Paper9667656

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

Tollenaar RA and 7 others. Br J Cancer, 1998. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Papers, record 9667656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9667656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
PubMed
Journal
Br J Cancer
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2019-05-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tollenaar RAR A
2van Krieken JHJ H
3van Slooten HJH J
4Bruinvels DJD J
5Nelemans KMK M
6van den Broek LJL J
7Hermans JJ
8van Dierendonck JHJ H

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
Tumor Suppressor Protein p53Major topic
Adolescent
Adult
Aged
Child
Child, Preschool
Female
Humans
Immunohistochemistry
Infant
Infant, Newborn
Male
Middle Aged
Prognosis
Survival Rate

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19020077Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.Science1997https://conductscience.org/library/papers/9020077PubMed
29020491Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.Br J Cancer1997https://conductscience.org/library/papers/9020491PubMed
39221816Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.Int J Cancer1997https://conductscience.org/library/papers/9221816PubMed
49303307The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry.EMBO J1997https://conductscience.org/library/papers/9303307PubMed
59365234Loss of function and p53 protein stabilization.Oncogene1997https://conductscience.org/library/papers/9365234PubMed
73722412Lymphocytic infiltration and survival in rectal cancer.J Clin Pathol1986https://conductscience.org/library/papers/3722412PubMed
82654431Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected].JAMA1989https://conductscience.org/library/papers/2654431PubMed
92253215p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.Cancer Res1990https://conductscience.org/library/papers/2253215PubMed
101905840p53 mutations in human cancers.Science1991https://conductscience.org/library/papers/1905840PubMed
111868464Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.Cancer Res1991https://conductscience.org/library/papers/1868464PubMed
121871110BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1871110PubMed
131551522Survival and acquired genetic alterations in colorectal cancer.Gastroenterology1992https://conductscience.org/library/papers/1551522PubMed
141568571The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma.Gastroenterology1992https://conductscience.org/library/papers/1568571PubMed
151569122Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.J Cell Sci1992https://conductscience.org/library/papers/1569122PubMed
161319835Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.Cancer Res1992https://conductscience.org/library/papers/1319835PubMed
171520594Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.Br J Cancer1992https://conductscience.org/library/papers/1520594PubMed
181360088Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.Lancet1992https://conductscience.org/library/papers/1360088PubMed
191451054Expression of p53 protein in invasive colorectal carcinomas of different histologic types.Cancer1992https://conductscience.org/library/papers/1451054PubMed
207678722p53 expression in colorectal adenomas.Am J Pathol1993https://conductscience.org/library/papers/7678722PubMed
218094072Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma.Int J Cancer1993https://conductscience.org/library/papers/8094072PubMed

See all 44 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
35686701Effect of KRAS mutations and p53 expression on the postoperative prognosis of patients with colorectal cancer.Mol Genet Genomic Med2022https://conductscience.org/library/papers/35686701PubMed
31471586Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.Mod Pathol2020https://conductscience.org/library/papers/31471586PubMed
29844818B-cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma.Oncol Lett2018https://conductscience.org/library/papers/29844818PubMed
28785155High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.World J Gastroenterol2017https://conductscience.org/library/papers/28785155PubMed
21732187FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer.Cancer Microenviron2013https://conductscience.org/library/papers/21732187PubMed
17426704Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.Br J Cancer2007https://conductscience.org/library/papers/17426704PubMed
15197496Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells.Cancer Immunol Immunother2004https://conductscience.org/library/papers/15197496PubMed
15065606p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases.Clin Exp Metastasis2004https://conductscience.org/library/papers/15065606PubMed
14714614Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer.Dig Dis Sci2003https://conductscience.org/library/papers/14714614PubMed
14627346Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study.Dig Dis Sci2003https://conductscience.org/library/papers/14627346PubMed
12833131Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.Cancer Gene Ther2003https://conductscience.org/library/papers/12833131PubMed
12827409Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature.Int J Colorectal Dis2004https://conductscience.org/library/papers/12827409PubMed
12594576A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.Cancer Immunol Immunother2003https://conductscience.org/library/papers/12594576PubMed
11349216Expression of Bcl-2 and c-ErbB-2 in colorectal neoplasia.Pathol Oncol Res2001https://conductscience.org/library/papers/11349216PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9667656

GET https://conductscience.org/api/papers/v1/9667656/references?page=2